I think insulin is yet another great example of why trickle down theories are bunk.
Our economic policy for decades has been mostly centered around pumping capital into markets to prop them up or grow them. The problem is there’s too much money pursuing too little novel work. Ironically, making billions of “surplus” dollars available to big companies drives lots of little command economies, not healthy markets. It makes more sense to corner the market on insulin or some foot fungus cream and rip people off than to create a new or improved product. There is very low R&D at improving anything associated with insulin because of rent seeking behaviors.
Profits don’t motivate research. Market activity does. I hope we learn from the successful aspects of COVID and pump money at people to make economic decisions for themselves.